Petauri Evidence
Pharmaceutical ManufacturingEngland, United Kingdom51-200 Employees
Petauri Evidence is a pharmaceutical services business unit within the Petauri platform, based in Bicester, England, United Kingdom (OX26 4PP), and employing 51-200 people. It provides support to pharmaceutical, biotechnology, and medical device companies to generate, apply, and communicate evidence to inform healthcare decision-making. Its programs cover evidence, pricing and access strategy; development of a robust evidence base; national, regional, and local reimbursement and formulary inclusion; and the communication of value to clinical and financial decision-makers. The unit has deep expertise across therapy areas, including rare disease, oncology, respiratory, diabetes and obesity, neurology, and immunology, and collaborates with industry leaders to advance global commercialization. Petauri Evidence was created in 2025 when Mtech Access joined Delta Hat, both joining the Petauri platform in 2024.